Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab effects on cutaneous sensory nerves in AD
NCT04520308Phase 4Unknown
- Start
- Sep 2020
- Primary completion
- Feb 2021
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of dupilumab in atopic dermatitis (AD). Status: unknown.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04520308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520308.